Skip to ContentSkip to Navigation
Practical matters How to find us prof. dr. P.G.M. (Peter) Mol


Contribution of Real-World Evidence in European Medicines Agency's Regulatory Decision Making

Safety-Related Drug Label Changes Following Large Post-Marketing Cardiometabolic Trials: A Review of European Public Assessment Reports

Translating Academic Drug Discovery Into Clinical Development: A Survey of the Awareness of Regulatory Support and Requirements Among Stakeholders in Europe

Aandacht voor vrouwen in geneesmiddelenonderzoek

Attention for sex in COVID-19 trials: a review of regulatory dossiers

Biomarker qualification at the European Medicines Agency: a review of biomarker qualification procedures from 2008 to 2020

Drug Regulatory Science: Collaborate to improve drug development and evaluation

Editorial: Insights in Regulatory Science 2021

Factors Influencing Preferences and Responses Towards Drug Safety Communications: A Conjoint Experiment Among Hospital-Based Healthcare Professionals in the Netherlands

Handling of New Drug Safety Information in the Dutch Hospital Setting: A Mixed Methods Approach

Read more